Michaela Levin
Chief Business Officer · Acrivon Therapeutics, Inc.
Individual
- 2026
- Sep 2, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michaela Levin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Blume-Jensen - $117K in ACRV purchases and sales in the last 12 months
- Eric Devroe - $18K in ACRV purchases and sales in the last 12 months
- Adam D. Levy - $17K in ACRV purchases and sales in the last 12 months
- Mary Miller - $3K in ACRV purchases and sales in the last 12 months
- Erick Gamelin - $804 in ACRV purchases and sales in the last 12 months
- Katharine Peterson - $203 in ACRV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michaela Levin?
Michaela Levin is a corporate insider, tracked as Chief Business Officer of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michaela Levin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
